The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Nobivac KC nasal drops, lyophilisate and solvent for suspension for dogs

Intervet Ireland LimitedVPA10996/129/001

Main Information

Trade NameNobivac KC nasal drops, lyophilisate and solvent for suspension for dogs
Active SubstancesBordetella bronchiseptica
Canine parainfluenza
Dosage FormNasal drops, lyophilisate and solvent for suspension
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/129/001

Group Information

ATC CodeQI07AF Live bacterial and viral vaccine
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued22/01/2001
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back